- Tumors1000+
- Pathologic Processes1000+
- Nervous System Diseases930
- Pathology826
- Mental Disorders745
Any
<10 miles
<30 miles
<50 miles
<70 miles
Filter Results
Condition
- Tumors1000+
- Pathologic Processes1000+
- Nervous System Diseases930
- Pathology826
- Mental Disorders745
Where are you looking?
How far are you willing to travel?Any
How old are you?
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
- HER2 negative
- PD-L1 positive
- ER positive
- HER2 positive
- EGFR positive
- EGFR negative
- KRAS positive
- PR positive
- ALK negative
- BRAF positive
- PD-L1 negative
- ER negative
- PR negative
- CD20 positive
- ALK positive
- BRAF negative
- BRCA1 positive
- IDH positive
- BRCA2 positive
- ROS1 negative
- HLA positive
- ROS1 positive
- p16 positive
- HLA-A positive
- HR positive
- TP53 positive
- PIK3CA positive
- CD19 positive
- IDH negative
- MET positive
- MYC positive
- dMMR positive
- NF1 positive
- RET positive
- ANA positive
- KRAS negative
- MSI-H positive
- NRAS positive
- NTRK positive
- PALB2 positive
- anti-dsDNA positive
- HBsAg positive
- MET negative
- MSS positive
- RAS positive
- p16 negative
- CFTR positive
- HPV negative
- HPV positive
- RET negative
- TP53 negative
- pMMR positive
- ABCA4 positive
- BCL2 positive
- BCR-ABL1 positive
- CCND1 positive
- NTRK negative
- RAS negative
- RB1 positive
- anti-Sm positive
- ctDNA positive
- BCL6 positive
- BRCA1 negative
- BRCA2 negative
- CD123 positive
- COL7A1 positive
- DMD positive
- HLA negative
- HLA-A negative
- MGMT negative
- PTEN positive
- RB1 negative
- TROP2 negative
- TROP2 positive
- AKT negative
- APP positive
- BRCA positive
- CD30 positive
- DLL3 positive
- FLT3 positive
- FMR1 positive
- HR negative
- HRAS positive
- MDM2 positive
- MGMT positive
- MMR negative
- MSI-H negative
- NRAS negative
- PSEN1 positive
- PSEN2 positive
- PTCH1 positive
- Philadelphia chromosome positive
- PiZZ positive
- RF positive
- RHO positive
- SMARCA4 positive
- dMMR negative
- 11q negative
- 11q positive
- AKT positive
- ALPL positive
- APOL1 positive
- ARID1A positive
- ATM positive
- Anti-PLA2R positive
- Aβ1-42 positive
- B7-H3 positive
- C5 positive
- CAG repeat in HTT positive
- CD5 positive
- CLDN18.2 positive
- EBV DNA positive
- EBV positive
- ER/PR positive
- FGFR2 positive
- FGFR3 positive
- FLT3 negative
- FOXO1 fusion negative
- GPC3 positive
- GRN positive
- HBB positive
- HBV DNA negative
- HBsAg negative
- HEXA positive
- HEXB positive
- HPV16 positive
- IGHV positive
- JAK2 positive
- KIT positive
- MLH1 positive
- MMR positive
- MSH2 positive
- MSH6 positive
- MSS negative
- MUC1 positive
- NF2 positive
- NPM1 positive
- NTRK1 positive
- NY-ESO-1 positive
- PDE6A positive
- PDE6B positive
- PIK3CA negative
- PIK3CD positive
- PIK3R1 positive
- PKLR positive
- PMM2 positive
- PMS2 positive
- PTEN negative
- Ph positive
- RAF positive
- SMARCB1 negative
- SPINK5 positive
- T790M positive
- TET2 positive
- TTR positive
- UBA1 positive
- UGT1A1 positive
- anti-AChR positive
- anti-MuSK positive
- anti-Ro autoantibodies positive
- anti-Ro/SSA positive
- anti-Smith positive
- t(11;14) positive
- 12 negative
- 12 positive
- 13q negative
- 13q positive
- 16p11.2 deletion positive
- 17p negative
- 17p positive
- 19q negative
- 19q positive
- 1p negative
- 1p positive
- 1p/19q co-deletion positive
- 1p/19q loss positive
- 1p36 deletion positive
- 46 XX karyotype positive
- 5q SMA positive
- 5q-autosomal recessive SMA positive
- AAVrh74 antibody titers negative
- ABL-class fusion positive
- ABL-class fusions positive
- ABO negative
- ABO positive
- ACVR1 positive
- AChR positive
- AChR-Ab positive
- ADAMTS-13 negative
- ADAMTS-13 positive
- AFP positive
- AKT1 E17K positive
- AKT1 positive
- ALT positive
- APC positive
- APOE e4 positive
- AQP4 positive
- ASXL1 positive
- ATA positive
- ATN1 positive
- Gleason Score 10
- Gleason Score 6
- Gleason Score 7
- Gleason Score 8
- Gleason Score 9
- Grade 1
- Grade 2
- Grade 3
- Grade 4
- Stage IV
- Stage III
- Stage II
- Stage I
- 1927nm Fractional Thulium Laser Treatment
- Adjuvant Therapy (except reconstruction)
- Anti-Seizure Medications (up to 2 types)
- Any Treatment for Pancreatic Cancer
- At least one prior tumor-directed therapy
- Avoidance of Activities That Cause Joint Pain
- Biologic Anti-Neoplastic Agent
- CD4+ > 350 cells/microliter for at least twelve months
- Cancer-Directed Surgery
- Cellular Therapies for ALS
Trial Status
Recruiting statusPlacebo
Recruiting
Waitlist Available
Administration Type
Trial Phase
Biomarkers
Stage of Disease
6167 trials
1
2
3
…50